CellSource Co (TSE:4880) Retained Earnings: 円3,104 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4880 CellSource Co Ltd TSE:4880
70 GF Score
Price 円320.00
GF Value 円775.06
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is CellSource Co Retained Earnings?

CellSource Co TSE:4880 +2.24% 70 Retained Earnings is 円3,104 Mil as of Apr. 2026. GuruFocus rates TSE:4880 with a GF Score™ of 70/100 and a GF Value™ of 円775.06 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. CellSource Co's retained earnings for the quarter that ended in Apr. 2026 was 円3,104 Mil.

CellSource Co's quarterly retained earnings declined from Apr. 2025 (円3,132 Mil) to Oct. 2025 (円3,132 Mil) and declined from Oct. 2025 (円3,132 Mil) to Apr. 2026 (円3,104 Mil).

CellSource Co's annual retained earnings declined from Oct. 2023 (円3,377 Mil) to Oct. 2024 (円3,220 Mil) and declined from Oct. 2024 (円3,220 Mil) to Oct. 2025 (円3,132 Mil).


CellSource Co  (TSE:4880) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


CellSource Co Retained Earnings Historical Data

* Premium members only.

The historical data trend for CellSource Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSource Co Retained Earnings Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only 1,436.33 2,454.18 3,377.32 3,220.05 3,131.68

CellSource Co Semi-Annual Data
Oct17 Oct18 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25 Apr26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,282.09 3,220.05 3,132.19 3,131.68 3,103.77
TSE:4880
70GF Score
CellSource Co Ltd TSE:4880
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSource Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of 円3,104 Mil mean?
CellSource Co (TSE:4880) has a Retained Earnings of 円3,104 Mil as of Apr. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on CellSource Co and its competitors.
Is CellSource Co's Retained Earnings too high?
CellSource Co's current Retained Earnings is 円3,104 Mil. Overall, CellSource Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellSource Co's Retained Earnings compare to VRTX and REGN?
CellSource Co's Retained Earnings of 円3,104 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on CellSource Co and its competitors. CellSource Co's current Retained Earnings is 円3,104 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSource Co stock overvalued right now?
Based on GuruFocus' analysis, CellSource Co (TSE:4880) is currently considered Significantly Undervalued. The stock's GF Value™ is 円775.06, compared to a current price of 円320.00 — trading 58.7% below its estimated fair value. The current Retained Earnings is 円3,104 Mil. CellSource Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For CellSource Co (TSE:4880), the current Retained Earnings is 円3,104 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSource Co (TSE:4880) Overvalued in 2026?

Based on GuruFocus' analysis, CellSource Co stock appears to be undervalued. The current stock price of 円320.00 is trading 58.7% below its estimated GF Value™ of 円775.06. GuruFocus considers CellSource Co to be Significantly Undervalued.

Key valuation signals for TSE:4880:

  • Retained Earnings: 円3,104 Mil
  • GF Value™: 円775.06 vs. price of 円320.00 (58.7% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the TSE:4880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellSource Co Business Description

Address Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
70GF Score

Get the complete analysis for TSE:4880

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円320.00
Price
円775.06
GF Value